Biogen to shut down its controversial Alzheimer’s drug Aduhelm

Biogen will stop developing its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster before stumbling soon after its launch a couple years ago.

Source: washingtontimes.com

Please follow and like us: